Echinacea |
Activation of cell-mediated immunity |
Allergic reactions, decreased effectiveness of immunosuppressants; potential for immunosuppression with long-term use |
No data |
|
Ephedra (ma huang) |
Increased HR and BP through direct and indirect sympathomimetic effects |
Risk of MI and stroke from tachycardia and htn; ventricular arrhythmias with halothane; long-term uses depletes endogenous catecholamines and may cause intraoperative hemodynamic instability; life-threatening interaction with MAOI's |
At least 24 hours before surgery |
|
Garlic |
Inhibition of platelet aggregation, increased fibrinolysis, equivocal antihypertensive activity |
Potential to increase risk of bleeding, especially when combined with other medications that inhibit platelet aggregation |
At least 7 days before surgery |
|
Ginkgo |
Inhibition of platelet-activating factor |
Potential to increase risk of bleeding, especially when combined with other medications that inhibit platelet aggregation |
At least 36 hours before surgery |
|
Ginseng |
Lowers blood glucose; inhibition of platelet aggregation; increased PT-PTT in animals; varied others |
Hypoglycemia; potential to increase risk of bleeding; potential to decrease anticoagulation effects of warfarin |
At least 7 days before surgery |
|
Kava |
Sedation, anxiolysis |
Potential to increase sedative effect of anesthetics; potential for addiction, tolerance, and withdrawal after abstinence unstudied |
At least 24 hours before surgery |
|
St. John's Wort |
Inhibition of neurotransmitter reuptake, MAO inhibition unlikely |
Induction of P450 enzymes (CYP 3A4) affecting cyclosporine, warfarin, steroids, protease inhibitors, and possibly benzo's, calcium channel blockers, and many other drugs; decreased serum digoxin levels |
At least 5 days before surgery |
|
Valerian |
|
|
|